95.23 - 97.14
55.47 - 103.81
1.63M / 1.81M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-12.54%
Negative revenue growth while FNV stands at 5.77%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-33.72%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-35.05%
Negative EBIT growth while FNV is at 2.94%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-35.05%
Negative operating income growth while FNV is at 1.39%. Joel Greenblatt would press for urgent turnaround measures.
-89.31%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-88.89%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-88.89%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.10%
Share count expansion well above FNV's 0.05%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.08%
Diluted share count expanding well above FNV's 0.05%. Michael Burry would fear significant dilution to existing owners' stakes.
-47.61%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-19.81%
Negative OCF growth while FNV is at 15.18%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
16.12%
FCF growth under 50% of FNV's 89.27%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
163.47%
10Y revenue/share CAGR 1.25-1.5x FNV's 129.73%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
-10.49%
Negative 5Y CAGR while FNV stands at 36.30%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
10.49%
3Y revenue/share CAGR under 50% of FNV's 38.70%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
171.76%
10Y OCF/share CAGR above 1.5x FNV's 91.44%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
-26.75%
Negative 5Y OCF/share CAGR while FNV is at 59.62%. Joel Greenblatt would question the firm’s operational model or cost structure.
-0.73%
Negative 3Y OCF/share CAGR while FNV stands at 70.75%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-6.14%
Negative 10Y net income/share CAGR while FNV is at 183.83%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-64.60%
Negative 5Y net income/share CAGR while FNV is 16.50%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
132.33%
3Y net income/share CAGR 50-75% of FNV's 188.98%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
222.43%
10Y equity/share CAGR above 1.5x FNV's 68.97%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
25.26%
5Y equity/share CAGR 1.25-1.5x FNV's 20.38%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
8.87%
Below 50% of FNV's 23.21%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
-23.77%
Negative 5Y dividend/share CAGR while FNV stands at 3.32%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
86.39%
3Y dividend/share CAGR above 1.5x FNV's 23.19%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-84.01%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
5.95%
Asset growth above 1.5x FNV's 1.10%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-1.00%
We have a declining book value while FNV shows 0.90%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
44.33%
Debt growth of 44.33% while FNV is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
No Data
No Data available this quarter, please select a different quarter.
-30.81%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.